Chaosheng Lu

495 citations
23 papers · 357 indexed · h-index 12
Topics
Neonatal Respiratory Health Research (3 papers)MicroRNA in disease regulation (3 papers)Congenital Diaphragmatic Hernia Studies (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Chaosheng Lu

21 papers receiving 354 citations

Peers

Chaosheng Lu
Comparison fields: 5 of 75
  • Molecular Biology 165
  • Epidemiology 74
  • Surgery 68
  • Cancer Research 60
  • Pulmonary and Respiratory Medicine 56
Replace Lingyan Fei with:
Lingyan Fei China
Montserrat Baldán‐Martín Spain
William H. Alarcon United States
Ho-Kee Yum South Korea
Lorenza Montagna Italy
Ryoko Ichikawa Japan
Zhaoxue Sheng China
Yunzhi Chen China
Yi‐Wei Lin China
Chaosheng Lu relative to Lingyan Fei China Lingyan Fei's profile →
Citations per field
00.5×4.8×
Lingyan Fei · 1×
Citations per year

Countries citing papers authored by Chaosheng Lu

Since Specialization
Citations

This map shows the geographic impact of Chaosheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaosheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaosheng Lu more than expected).

Fields of papers citing papers by Chaosheng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaosheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaosheng Lu. The network helps show where Chaosheng Lu may publish in the future.

Co-authorship network of co-authors of Chaosheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chaosheng Lu. A scholar is included among the top collaborators of Chaosheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaosheng Lu. Chaosheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 21
5 4
6 7
7 1
8 4
9 17
10 28
11 13
12 25
13 20
14 20
15 43
16 30
17 5
18
Dehydrocostus lactone suppresses ox-LDL-induced attachment of monocytes to endothelial cells.
6
19 25
20 52

About Chaosheng Lu

Chaosheng Lu is a scholar working on Clinical Biochemistry, Developmental Neuroscience and Cancer Research, having authored 23 papers that have together received 357 indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (3 papers), MicroRNA in disease regulation (3 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). The work is most often cited by research in Cancer Research (60 citations), Nephrology (18 citations) and Molecular Biology (165 citations). Chaosheng Lu has collaborated with scholars based in China and United States. Frequent co-authors include Huachun Weng, Yi Tan, Congcong Chen, Yan Qian, Lu Cai, Yuanyuan Sun, Haiyan Li, Bicheng Chen, Qiu Wang and Xixi Zhang. Their work appears in journals such as Diabetes, Scientific Reports and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026